Search research articles
Contact Us
Filters
Showing results (11-20 of 167) with videos related to
Page
of 17
Sort By:
Trends in Endocrinology and Metabolism: TEM
|
July 14, 2012
Action of RORs and their ligands in (patho)physiology
Laura A Solt, Thomas P Burris
Current Pharmaceutical Design
|
March 8, 2011
A role for rev-erbα ligands in regulation of adipogenesis
Douglas J Kojetin, Thomas P Burris
Nature Reviews. Drug Discovery
|
March 1, 2014
REV-ERB and ROR nuclear receptors as drug targets
Douglas J Kojetin, Thomas P Burris
Frontiers in Endocrinology
|
July 27, 2017
Metabolic Characterization of a Novel RORα Knockout Mouse Model without Ataxia
Cyrielle Billon, Sadichha Sitaula, Thomas P Burris
Biochemical Pharmacology
|
June 16, 2015
Anti-proliferative actions of a synthetic REV-ERBα/β agonist in breast cancer cells
Yongjun Wang, Douglas Kojetin, Thomas P Burris
Molecular Metabolism
|
October 1, 2016
Inhibition of RORα/γ suppresses atherosclerosis via inhibition of both cholesterol absorption and inflammation
Cyrielle Billon, Sadichha Sitaula, Thomas P Burris
Trends in Molecular Medicine
|
December 3, 2014
Clock genes, pancreatic function, and diabetes
Elaine Vieira, Thomas P Burris, Ivan Quesada
The Journal of Biological Chemistry
|
March 25, 2010
Regulation of FGF21 expression and secretion by retinoic acid receptor-related orphan receptor alpha
Yongjun Wang, Laura A Solt, Thomas P Burris
Biochemical and Biophysical Research Communications
|
February 19, 2008
Relationship between circadian oscillations of Rev-erbalpha expression and intracellular levels of its ligand, heme
Pamela M Rogers, Ling Ying, Thomas P Burris
Molecular Genetics and Metabolism
|
October 3, 2002
Genetic disorders associated with ATP binding cassette cholesterol transporters
Thomas P Burris, Patrick I Eacho, Guoqing Cao
Page
of 17
Search research articles
Search
Showing results (11-20 of 167) with videos related to
Sort By:
Page
of 17
Trends in Endocrinology and Metabolism: TEM
|
July 14, 2012
Action of RORs and their ligands in (patho)physiology
Laura A Solt, Thomas P Burris
Current Pharmaceutical Design
|
March 8, 2011
A role for rev-erbα ligands in regulation of adipogenesis
Douglas J Kojetin, Thomas P Burris
Nature Reviews. Drug Discovery
|
March 1, 2014
REV-ERB and ROR nuclear receptors as drug targets
Douglas J Kojetin, Thomas P Burris
Frontiers in Endocrinology
|
July 27, 2017
Metabolic Characterization of a Novel RORα Knockout Mouse Model without Ataxia
Cyrielle Billon, Sadichha Sitaula, Thomas P Burris
Biochemical Pharmacology
|
June 16, 2015
Anti-proliferative actions of a synthetic REV-ERBα/β agonist in breast cancer cells
Yongjun Wang, Douglas Kojetin, Thomas P Burris
Molecular Metabolism
|
October 1, 2016
Inhibition of RORα/γ suppresses atherosclerosis via inhibition of both cholesterol absorption and inflammation
Cyrielle Billon, Sadichha Sitaula, Thomas P Burris
Trends in Molecular Medicine
|
December 3, 2014
Clock genes, pancreatic function, and diabetes
Elaine Vieira, Thomas P Burris, Ivan Quesada
The Journal of Biological Chemistry
|
March 25, 2010
Regulation of FGF21 expression and secretion by retinoic acid receptor-related orphan receptor alpha
Yongjun Wang, Laura A Solt, Thomas P Burris
Biochemical and Biophysical Research Communications
|
February 19, 2008
Relationship between circadian oscillations of Rev-erbalpha expression and intracellular levels of its ligand, heme
Pamela M Rogers, Ling Ying, Thomas P Burris
Molecular Genetics and Metabolism
|
October 3, 2002
Genetic disorders associated with ATP binding cassette cholesterol transporters
Thomas P Burris, Patrick I Eacho, Guoqing Cao
Page
of 17